Cyclosporin galenic forms

US7511014B2 · kind B2 · utility

Assignee

• Novartis AG · CH

Inventors

• Thomas Cavanak · Biel-Benken, CH
• Ulrich Posanski · Glückstadt, DE

Key dates

• Filing date: Jun 15, 2006
• Grant date: Mar 31, 2009
• Expiry date: Jun 15, 2026

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K47/44
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.